What is Provectus Algae?
Provectus Algae operates at the intersection of biotechnology and industrial sustainability, specializing in the transformation of natural biological processes into scalable, carbon-negative solutions. The company has engineered a proprietary, end-to-end platform that streamlines the development of algae-based bioproducts, effectively managing the entire lifecycle from initial research and development to full-scale commercialization. By integrating these complex workflows, Provectus Algae provides a robust infrastructure for sustainable biomanufacturing, addressing the growing global demand for environmentally conscious alternatives to traditional chemical and material production methods. Its market position is defined by its ability to deliver high-performance, bio-derived inputs that meet the rigorous standards of enterprise-level supply chains.
How much funding has Provectus Algae raised?
Provectus Algae has raised a total of $24M across 2 funding rounds:
Other Financing Round
$11.4M
Series A
$12.6M
Other Financing Round (2021): $11.4M with participation from Acequia Capital, Hitachi Ventures, and Possible Ventures
Series A (2025): $12.6M led by OneVentures, Mort, and Hitachi Ventures
Key Investors in Provectus Algae
OneVentures
OneVentures is a prominent Australian venture capital firm that invests in high-growth technology and healthcare companies, providing both capital and operational expertise to scale businesses globally.
Mort
Mort & Co is a leading Australian agricultural enterprise specializing in large-scale cattle lot feeding and supply chain management, bringing deep expertise in sustainable resource management and industrial-scale production.
Hitachi Ventures
Hitachi Ventures GmbH is the corporate venture arm of Hitachi, focusing on strategic investments in digital, industrial, and environmental technologies to foster global innovation and sustainable infrastructure.
What's next for Provectus Algae?
With the successful closure of this Series A financing, Provectus Algae is poised to accelerate its commercial deployment strategy. The capital will likely be directed toward scaling production capacity and enhancing the efficiency of its proprietary biomanufacturing platform. As the company transitions into a more mature phase of its lifecycle, the focus will shift toward deepening partnerships with industrial stakeholders and optimizing its supply chain to meet the increasing demand for carbon-negative bioproducts. By leveraging the expertise of its strategic backers, Provectus Algae is well-positioned to solidify its leadership in the bio-economy, driving innovation that aligns with global decarbonization targets and sustainable industrial practices.
See full Provectus Algae company page
